Nathan Ashby, DPM
Foot Surgery · Jamesville, NYNPI 1003995275
Payments from drug & device makers
Across 18 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$95
- Organogenesis Inc.$59
- Pacira Pharmaceuticals Incorporated$46
- Paratek Pharmaceuticals, Inc.$38
- Solventum Corporation$33
- AbbVie$27
- plus $164 from 8 others
What the payments were for
- Food & beverage$463100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 1 | $95 |
| Organogenesis Inc. | 2 | $59 |
| Pacira Pharmaceuticals Incorporated | 2 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Solventum Corporation | 1 | $33 |
| AbbVie | 1 | $27 |
| Vertex | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Aroa Biosurgery Incorporated | 2 | $23 |
| Averitas Pharma Inc. | 1 | $23 |
| Nabriva Therapeutics, PLC | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Kerecis Limited | 1 | $12 |
How this compares
$463 in reported general payments places this provider in the 50th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $456 |
| Doxycycline Hyclate | 17 | $166 |
| Methylprednisolone | 15 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Jamesville
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
- Charles MorelliMamaroneck$18K
- Evan BrethBrooklyn$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.